CTSH and diabetic maculopathy: Leveraging consortium-level genetic data (eQTLGen, GTEx) and functional validation (GSE94019, GSE102485), we identified Cathepsin H as a key pathogenic driver of PDR and diabetic maculopathy, with robust evidence from GSMR, MVMR, and cis-eQTL-based SMR.